Source document
Loading document…
KPIsSections1
Sections in this filing
Changes / Accountants
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description of Exhibits 99.1 Corporate Presentation, dated July 2026. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ENGENE THERAPEUTICS INC. Date: July 17, 2026 By: /s/ Ronald H. W. Cooper Name: Ronald H. W. Cooper Title: Chief Executive Officer and President